eGenesis
PrivateLast Round
Series D
Sep 4, 2024
Total Funding Raised
$454M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
eGenesis is a biotechnology company that specializes in gene editing and genome engineering to revolutionize solid organ and therapeutic cell transplantation for life-threatening diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
eGenesis Comparables
Compare eGenesis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| United Therapeutics | 81% | |
| Makana Therapeutics | 79% | |
| NZeno | 79% | |
eGenesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 4, 2024 | ||||
| Series C | Mar 2, 2021 | ||||
| Series B | Nov 7, 2019 | ||||
| Series A | Mar 16, 2017 |
Key People
Founding team and executive leadership
eGenesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SymBiosis Capital Management | Series C |
| Farallon Capital Management | Series D, Series C |
| LifeSci Venture Partners | Series C |
| Khosla Ventures | Series D, Series B, Series A, Series C |
| Parkwood | Series D |
| ARCH Venture Partners | Series D, Series B, Series C, Series A |
| Eisai Innovation | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Conducting clinical study for EGEN-2784 at Massachusetts General Hospital.
- Mar 24, 2026
Named to Fast Company's World's Most Innovative Companies list for 2026.
eGenesis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about eGenesis's valuation, stock price, and market status.